CVS Health Corporation announced on Wednesday that its revenue in the third quarter of the fiscal year 2023 observed an annual rise of 10.6% to hit $89.8 billion. The company also reported a net income of $2.26 billion, an improvement compared to a net loss of $3.4 billion registered in the same trimester in 2022. Meanwhile, it also scored diluted earnings per share (EPS) of $1.75, in contrast with losses per share of $2.59 year-on-year.
"Our colleagues helped us deliver another quarter of positive results across our business areas. Despite a challenging business environment, we continue adapting to the changing needs of our consumers by connecting our care delivery capabilities in communities across the country, broadening access to care and lowering costs," President and Chief Executive Officer (CEO) Karen S. Lynch said.
Following the release of the report, CVS's stock grew by 0.85% in premarket trading.
